|
Volumn 94, Issue 4 SUPPL., 2002, Pages 1363-1372
|
High-dose myeloablative radioimmunotherapy of mantle cell non-Hodgkin lymphoma with the iodine-131-labeled chimeric anti-CD20 antibody C2B8 and autologous stem cell support: Results of a pilot study
|
Author keywords
Anti CD20 antibody; High dose myeloablative therapy; Mantle cell non Hodgkin lymhpoma; Radioimmunotherapy; Stem cell transplantation
|
Indexed keywords
CD20 ANTIGEN;
IODINE 131;
RITUXIMAB;
ADULT;
AUTOTRANSPLANTATION;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
CLINICAL ARTICLE;
CONFERENCE PAPER;
DOSIMETRY;
DRUG EFFICACY;
FEMALE;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMAN;
MALE;
MANTLE CELL LYMPHOMA;
NONHODGKIN LYMPHOMA;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIOIMMUNOTHERAPY;
TREATMENT OUTCOME;
RETRACTED ARTICLE;
|
EID: 0037083476
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/cncr.10307 Document Type: Conference Paper |
Times cited : (62)
|
References (21)
|